Genetically modified herpes virus delivers one-two punch against advanced cancers

Pin-prick blood test identifies immunity to COVID-19
23 September 2022
A review of mobile sensing in the COVID-19 era
23 September 2022

Genetically modified herpes virus delivers one-two punch against advanced cancers

A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial.

Comments are closed.